CRO Industry Pulse

Criterium, Inc. to Exhibit at 43rd Annual Drug Information Assn. Meeting in Atlanta, GA on June 17-20th.

Regarded as the event of the year for Pharmaceutical and Related Industries, Criterium, Inc. is once again delighted to be one of the exhibitors at the Georgia World Congress Center as part of the 43rd DIA Annual Meeting.

All DIA attendees are invited to GET TO KNOW US and visit with Criterium representatives at booth # 836. There will be several presentations that detail our agile approach to technology-based solutions that have enabled Criterium to grow and service clients worldwide.

During the Meeting on Monday, June 18th a 2-part Outsourcing / Clinical Research and Development seminar entitled Lessons Learned: A Nonconfrontational Technique to
Improve Sponsor-Provider Team Performance will be chaired by John R. Vogel, PhD, Drug Development Consultant, John R. Vogel Associates, Inc. and will feature presentations from Ronny K. Schnel, MA, Executive Director, Business Development and Client Services for Criterium Inc. and Larry A. Blankstein, PhD, Senior Director, Clinical Research, Genzyme Corporation.

The panel will describe a lessons learned process and review the results of lessons learned performed between a Sponsor and a Vendor. Attendees will actually participate in a lessons learned process by using a dial-up toll free number to answer questions about their most recent Sponsor/Vendor experience. The survey results will be used to discuss better ways to design and manage outsourced projects.

This year’s Keynote Speaker is Dr. Julie Louise Gerberding, MD, MPH, who is the Director of the Centers for Disease Control and Prevention (CDC) and the Administrator of the Agency for Toxic Substances and Disease Registry.